Table 6, Summary of in vitro ADMET/PK Properties of NOD1 Inhibitor Probe - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf

Warning: The NCBI web site requires JavaScript to function. more...

Table 6Summary of in vitro ADMET/PK Properties of NOD1 Inhibitor Probe

Probe CID Probe ML# BCCG MLS-#	Aqueous Solubility (μg/mL)^a (@ pH)	PAMPA Pe (x10⁻⁶ cm/s)^b (@ pH)	Plasma Protein Binding (% Bound)		Plasma Stability^c Human Mouse/	Hepatic Microsome Stability^d Human/Mouse	Hepatic Toxicity^e LC50 (μM)
Probe CID Probe ML# BCCG MLS-#	Aqueous Solubility (μg/mL)^a (@ pH)	PAMPA Pe (x10⁻⁶ cm/s)^b (@ pH)	Human 1μM/10μM	Mouse 1μM/10μM	Plasma Stability^c Human Mouse/	Hepatic Microsome Stability^d Human/Mouse	Hepatic Toxicity^e LC50 (μM)
CID5310346	0.57 (5.0)	1269 (5.0)	99.41/97.38	98.81/97.20	100/100	8.82/0.86	>50
ML146	0.66 (6.2)	1516 (6.2)
MLS-012325	0.62 (7.4)	1344 (7.4)

a: in aqueous buffer, pH’s 5.0/6.2/7.4
b: in aqueous buffer; Donor compartment pH’s 5.0/6.2/7.4; Acceptor compartment pH 7.4
c: % remaining at 3 hr
d: % remaining at 1 hr
e: towards Fa2N-4 immortalized human hepatocytes

From: High Throughput Screening Assays for NOD1 Inhibitors - Probe 2

Cover of Probe Reports from the NIH Molecular Libraries Program

Probe Reports from the NIH Molecular Libraries Program [Internet].

Bethesda (MD): National Center for Biotechnology Information (US); 2010-.

Copyright Notice

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.